
Indoco Remedies Limited has informed the Exchange regarding a press release dated January 30, 2026, titled "Indoco Remedies receives final ANDA approval from USFDA for Lacosamide Oral Solution USP,10mg/mL".
Filed with NSE · · 2 pages · English

Indoco Remedies Limited has informed the Exchange regarding a press release dated January 30, 2026, titled "Indoco Remedies receives final ANDA approval from USFDA for Lacosamide Oral Solution USP,10mg/mL".
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies